We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$88.2B
AUM Growth
+$1.6B
Cap. Flow
-$4.17B
Cap. Flow %
-4.73%
Top 10 Hldgs %
15.24%
Holding
1,971
New
331
Increased
444
Reduced
869
Closed
74

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$314M
2
TSM icon
TSMC
TSM
+$302M
3
GPC icon
Genuine Parts
GPC
+$301M
4
FR icon
First Industrial Realty Trust
FR
+$131M
5
DLTR icon
Dollar Tree
DLTR
+$92.3M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$354M
2
COP icon
ConocoPhillips
COP
+$339M
3
ADM icon
Archer Daniels Midland
ADM
+$275M
4
WNS
WNS Holdings
WNS
+$149M
5
PAYC icon
Paycom
PAYC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 25.38%
2 Healthcare 13.98%
3 Financials 12.4%
4 Industrials 10.85%
5 Consumer Discretionary 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLC icon
1626
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$28 ﹤0.01%
+347
New +$27K
SMBK icon
1627
SmartFinancial
SMBK
$855M
$27 ﹤0.01%
+1,261
New +$27.9K
URG
1628
Ur-Energy
URG
$485M
$27 ﹤0.01%
+16,654
New +$27.7K
CRML icon
1629
Critical Metals Corp
CRML
$853M
$27 ﹤0.01%
+2,482
New +$26.7K
QVCGA
1630
DELISTED
QVC Group Inc Series A
QVCGA
$26 ﹤0.01%
+431
New +$22.5K
ESPR
1631
DELISTED
Esperion Therapeutics
ESPR
$25 ﹤0.01%
+9,215
New +$22.4K
REAX icon
1632
Real Brokerage
REAX
$368M
$25 ﹤0.01%
+8,072
New +$22.1K
GETY icon
1633
Getty Images
GETY
$184M
$24 ﹤0.01%
+5,865
New +$27.2K
TALK icon
1634
Talkspace
TALK
$873M
$24 ﹤0.01%
+6,702
New +$18.2K
KYTX icon
1635
Kyverna Therapeutics
KYTX
$450M
$24 ﹤0.01%
+950
New +$26.5K
ROOT icon
1636
Root
ROOT
$917M
$23 ﹤0.01%
+376
New +$8.85K
SYM icon
1637
Symbotic
SYM
$5.11B
$23 ﹤0.01%
+521
New +$22.8K
TSHA icon
1638
Taysha Gene Therapies
TSHA
$1.59B
$23 ﹤0.01%
+8,066
New +$16.8K
SRG
1639
Seritage Growth Properties
SRG
$130M
$22 ﹤0.01%
+2,287
New +$21.5K
IVVD icon
1640
Invivyd
IVVD
$180M
$21 ﹤0.01%
+4,784
New +$19.8K
NCMI icon
1641
National CineMedia
NCMI
$354M
$21 ﹤0.01%
+4,089
New +$17.4K
CRBP icon
1642
Corbus Pharmaceuticals
CRBP
$170M
$20 ﹤0.01%
+507
New +$12.5K
JSPR icon
1643
Jasper Therapeutics
JSPR
$22.9M
$20 ﹤0.01%
+697
New +$12.4K
GRPN icon
1644
Groupon
GRPN
$980M
$19 ﹤0.01%
+1,459
New +$22.2K
KVYO icon
1645
Klaviyo
KVYO
$4.91B
$19 ﹤0.01%
+732
New +$19.6K
AMED
1646
DELISTED
Amedisys
AMED
$18 ﹤0.01%
+196
New +$18.4K
RUM icon
1647
RUM Group Inc
RUM
$1.57B
$18 ﹤0.01%
+2,227
New +$14.4K
STTK icon
1648
Shattuck Labs
STTK
$710M
$18 ﹤0.01%
+2,055
New +$18.8K
AKBA icon
1649
Akebia Therapeutics
AKBA
$327M
$17 ﹤0.01%
+9,170
New +$14.7K
CATX icon
1650
Perspective Therapeutics
CATX
$332M
$17 ﹤0.01%
+1,399
New +$11.9K

Similar funds

Macquarie Group's Q1 2024 Portfolio in Review

As of Q1 2024, Macquarie Group held 1,971 positions worth $88.2B, up 1.9% from $86.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group withdrew a net $4.17B in Q1 2024, closing 74 positions and reducing 869 holdings. Its most notable exit was Littelfuse, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Nextpower Inc worth $71.7M.

  • Macquarie Group's largest Q1 2024 buy was Nextpower Inc: 1,273,463 shares worth $71.7M.
  • Macquarie Group added most to ExxonMobil in Q1 2024, an estimated $314M increase.
  • Macquarie Group's biggest Q1 2024 reduction was RTX Corp, cutting an estimated $354M.
  • Macquarie Group fully exited Littelfuse in Q1 2024, selling an estimated $122M.
  • Macquarie Group's ten largest holdings make up 15% of its $88.2B portfolio in Q1 2024.
  • Macquarie Group opened 331 new positions and closed 74 in Q1 2024.
  • Macquarie Group's portfolio value rose 1.9% quarter-over-quarter to $88.2B.

Based on Macquarie Group's 13F filing for Q1 2024, filed 14 May 2024.